Novartis Consumer Health - Effective innovation in OTC

Vario has worked with Novartis Consumer Health over the last 5 years on many of its key brands including:

Fenistil
Lamisil
Otrivine
Voltaren

We have been involved in major initiatives which have led to increase in market share and in some cases such as Fenistil Coldsore and Lamisil Once, number one position in key markets.

Vario has extensive OTC experience, with strong understanding of cross border legislative issues. This combined with years working on FMCG brands and understanding consumer needs...provides a healthy mix which inspires our creativity and helps our clients create a point of difference, driving sales and brand growth - essential with the ongoing shift from POM to P and the gradual relaxing of market legislation allowing for more creative solutions.

Novartis Consumer Healthcare has announced that Lamisil is now the "Number 1" brand in the athlete's foot sector with a 38.6 per cent share of the market. Source: ICP (UK) Sept 2006**

**This leading position has been directly attributed to the launch of Lamisil Once